It was always Coops intention to incorporate the Chinese market as well....
and he has plenty of reasons to do so..
Coops got plenty of connections established in China since he took over Atcor and propelled the company to the next level. He was always the missing link to make Atcor with their Spygmocor technology a successful company. What he achieved in the Chinese market in only 3 years is only staggering.....
Validated in many Chinese studies ....
Approved by the CFDA and commercially available to hospitals in China....
China FDA approval achieved for Oscar 2.....
Cardiex and InHealth collaboration with leading Chinese Telemedicine platform Health160 to deploy in health solutions across China....
Cardiex announced joint venture with largest Google wearable platform partner in China....
Cardiex appointed new Chinese distributor to drive growth and new market opportunities.....
Cardiex announced partnership with Andon for Pulse and other wearables.....
And of today we got a second manufacturing partnership with Fenda Technology for our Conneqt brand.
This shows a clear path to integrate into the Chinese market and Coops vision to be a Global Mayor player in the wearable and Telehealth market. His connections he established since he took over Atcor are mind-blowing and have the potential to make his dreams are coming true to become a billion $ company....a multi bagger in the makings
